Nordblom Company signs Augmenix to 21,000 s/f lease at 201 Burlington Rd., Bedford, MA

Bedford, MA Nordblom Company has completed a 21,000 s/f lease with Augmenix Inc. Augmenix is a privately held medical device company focused on the development and commercialization of radiation oncology and urology products using its proprietary hydrogel technology. They will move their corporate headquarters from Waltham to 201 Burlington Rd. later this year.

201 Burlington Road - Bedford, MA

201 Burlington Rd. consists of two connected office buildings totaling 135,000 s/f. The buildings have received considerable improvements, including a complete demo-to-structure renovation which provides for a dramatic two-story atrium lobby, a new metal façade, energy efficient windows, advanced systems and landscape work. Nordblom has also invested in a new, on-site cafe, bike storage, fitness facility and shower/locker facilities to create a first class office campus.

Nearby amenities include a wide range of restaurants and retail, as well as MBTA bus service at the front door accessing both the Lowell and Alewife train stations. Situated in the center of the Rte. 128/Rte. 3 Tech Corridor, 201 Burlington Rd. offers access to the region’s central highways and visibility from Rte. 3 at Exit 26.

“We are thrilled that Augmenix will be our newest growth company in this dynamic building,” said Og Hunnewell, partner at Nordblom Company. “They are the perfect tenant for this forward-looking property,” he continued.

“201 Burlington was the ideal choice for Augmenix due to its easy access to Rtes. 3 and 128, proximity to surrounding amenities, and professional curb appeal,” said John Pedersen, CEO of Augmenix. “Recognized by Inc. 5000 as one of the fastest growing private companies in the nation and the metro Boston area, we are excited to be tripling our footprint in support of our growing operations and look forward to our new headquarters in Bedford.”

Nordblom Company is a real estate enterprise with a 90-year history of investing, managing and developing properties throughout the New England region and select markets across the country. The company currently owns office, commercial and multi-family properties in the New England and Carolina markets and is committed to creating dynamic work and living environments that further the quality of life for the people who occupy its properties. Headquartered in Burlington, Massachusetts with offices in Boston, Brookline, and Raleigh, North Carolina, Nordblom Company has $1.2 billion in assets under management.

Augmenix, Inc. is a privately held company based in the Boston area focused on the development and commercialization of radiation oncology products using its proprietary hydrogel technology. The company was founded by Incept LLC in 2008 and is funded by several leading venture capital groups.